Perioperative predictors for complications in patients with Xanthogranulomatous Pyelonephritis treated with nephrectomy.


Journal

Urologia
ISSN: 1724-6075
Titre abrégé: Urologia
Pays: United States
ID NLM: 0417372

Informations de publication

Date de publication:
May 2023
Historique:
medline: 14 6 2023
pubmed: 30 6 2022
entrez: 29 6 2022
Statut: ppublish

Résumé

Xanthogranulomatous pyelonephritis is an inflammatory disease characterized by chronic obstruction and infection. This pathology is a life-threatening condition when surgical treatment is carried out. We decided to retrospectively evaluate whether there were perioperative factors that predict complications in patients who undergo nephrectomy. We reviewed all nephrectomies done in the period of 2013-2018, in a tertiary referral Hospital with the histopathological diagnosis of Xanthogranulomatous Pyelonephritis. The presence of renal abscess at admission was observed as a risk factor associated with perioperative complications ( Anemia and the presence of abscess were important perioperative factors that predict perioperative complications.

Identifiants

pubmed: 35765747
doi: 10.1177/03915603221107135
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

220-223

Auteurs

Fred Alain Montelongo-Rodríguez (FA)

Urology Department, Hospital Universitario "Dr. José Eleuterio González," Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Monterrey, México.

Rigoberto Pallares-Mendez (R)

Urology Department, Hospital Universitario "Dr. José Eleuterio González," Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Monterrey, México.

José Iván Robles-Torres (JI)

Urology Department, Hospital Universitario "Dr. José Eleuterio González," Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Monterrey, México.

Rodrigo Romero-Mata (R)

Urology Department, Hospital Universitario "Dr. José Eleuterio González," Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Monterrey, México.

Daniel Eduardo Cervantes-Miranda (DE)

Urology Department, Hospital Universitario "Dr. José Eleuterio González," Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Monterrey, México.

Adrián Gutiérrez-González (A)

Urology Department, Hospital Universitario "Dr. José Eleuterio González," Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Monterrey, México.

Jorge Ángel García-Arreola (JÁ)

Facultad de Medicina, Hospital Universitario "Dr. José Eleuterio González," Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Monterrey, México.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH